Company Filing History:
Years Active: 2020-2025
Title: Olivier Dalmas: Innovator in Cancer Immunotherapy
Introduction
Olivier Dalmas is a prominent inventor based in San Carlos, CA (US). He has made significant contributions to the field of cancer immunotherapy, holding a total of 4 patents. His work focuses on the identification and targeting of antigen-specific T cells, which is crucial for developing effective cancer treatments.
Latest Patents
Dalmas's latest patents include groundbreaking innovations such as "Compositions and methods for identification of antigen specific T cells." This patent discloses antigenic peptide-MHC complexes, referred to as comPACT polypeptides and comPACT polynucleotides. The methods outlined in this patent enable the production of these complexes and libraries of comPACT polynucleotides and polypeptides. They are exemplarily used in capturing cancer neoepitope-reactive T cells with high accuracy. Another notable patent is "Dual particle detection approaches for detection of neoantigen specific T cells," which provides improved sensitivity and specificity in detecting these T cells. Additionally, the patent includes signal-to-noise ratio analysis of isolated T cells for enhanced detection of neoantigen-specific T cells.
Career Highlights
Throughout his career, Olivier Dalmas has worked with notable companies such as Adoc Ssf, LLC and Pact Pharma, Inc. His experience in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in cancer research.
Collaborations
Dalmas has collaborated with esteemed colleagues, including Songming Peng and Zheng Pan. These partnerships have facilitated the exchange of ideas and expertise, enhancing the impact of his work in the field.
Conclusion
Olivier Dalmas is a key figure in the realm of cancer immunotherapy, with a focus on innovative methods for identifying and targeting T cells. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.